Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy-Reference-Cited by-同舟云学术

Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy

Published:2009-04 Issue:4 Volume:72 Page:393-397
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Pütz Gerhard,Schmah Oliver,Eckes Jürgen,Hug Martin J.,Winkler Karl

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer;Chang;Eur J Cancer,2000

2. Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-positive breast cancer;Bonadonna;N Engl J Med,1995

3. Drug delivery systems: entering the mainstream;Allen;Science,2004

4. Pharmakokinetics of pegylated liposomal doxorubicin;Gabizon;Clin Pharmakokinet,2003

5. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors;Drummond;Pharmacol Rev,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years;Pharmaceutics;2020-09-30

2. Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing;Current Drug Delivery;2018-09-25

3. Plasma filtration for the controlled removal of liposomal therapeutics – From the apheretic site of view;Atherosclerosis Supplements;2017-11

4. Taming the Wildness of “Trojan-Horse” Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents;ACS Applied Materials & Interfaces;2017-03-14

5. Accumulating nanoparticles by EPR: A route of no return;Journal of Controlled Release;2016-09